MentionFox
Home › Stakes › Verona Pharma Plc
5%+ stakes · Schedule 13D and 13G

Verona Pharma Plc: 5%+ holders

Who has reported owning 5% or more of Verona Pharma Plc, from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more1
Filings7
Latest filing2025-11-14

Verona Pharma Plc has 7 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of american depositary shares. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
BlackRock Portfolio Management LLC6%27,645,624SCHEDULE 13G, 2025-10-172025-09-30
Janus Henderson Group Plc1.2%1,010,564SCHEDULE 13G/A, 2025-11-142025-09-30
RA Capital Management, L.P.0.7%593,670SCHEDULE 13G/A, 2025-08-142025-06-30
Perceptive Advisors LLC0%0SCHEDULE 13G/A, 2025-11-142025-09-30
Pentwater Capital Management LP0%0SCHEDULE 13G, 2025-11-142025-09-30

Timeline

FiledHolderPercentFiling
2025-08-14Perceptive Advisors LLC6.4%SCHEDULE 13G/A
2025-08-14Janus Henderson Group Plc7.2%SCHEDULE 13G/A
2025-08-14RA Capital Management, L.P.0.7%SCHEDULE 13G/A
2025-10-17BlackRock Portfolio Management LLC6%SCHEDULE 13G
2025-11-14Pentwater Capital Management LP0%SCHEDULE 13G
2025-11-14Perceptive Advisors LLC0%SCHEDULE 13G/A
2025-11-14Janus Henderson Group Plc1.2%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Verona Pharma Plc. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/verona-pharma
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Verona Pharma Plc 5%+ holders: 1 at 5% or more, largest BlackRock Portfolio Management LLC 6%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/verona-pharma